Monday, August 24, 2026

HomeBusiness NewsBallarat cryopreservation biotech Vitrafy lists on ASX

Ballarat cryopreservation biotech Vitrafy lists on ASX

- Advertisement -



A Ballarat-founded biotech led by former Virtus Health CEO Kate Munnings has successfully completed a $35 million initial public offering (IPO) on the Australian Securities Exchange, as Vitrafy Life Sciences (ASX: VFY) looks to commercialise its cryopreservation technology.

Headquartered in…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed